Clinical activity and safety of rilzabrutinib in patients with previously treated immune thrombocytopenia (LUNA3): results from the open-label period of a phase 3 trial

The Lancet Haematology · Elsevier

Аннотация

Publication date: October 2026 Source: The Lancet Haematology, Volume 13, Issue 10 Author(s): David J Kuter, Waleed Ghanima, Nichola Cooper, Howard A Liebman, Lei Zhang, Yu Hu, Yoshitaka Miyakawa, Marie Luise Hütter-Krönke, Cristina Pascual-Izquierdo, Elisa Lucchini, Sylvain Audia, Matias Cordoba, Heidi Krenz, Mengjie Yao, Ahmed Daak

Читать у издателя →

Похожие статьи